查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1751009

2025年全球胃肠道粪便检验市场报告

GI Stool Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，胃肠道粪便检验市场规模将强劲成长。 2029年，该市场规模将成长至18.7亿美元，年复合成长率（CAGR）为7.3%。预测期内的增长可归因于对高效诊断设备的需求不断增长、结直肠癌发病率上升、医疗保健支出不断增加、快餐消费量不断增加以及对个性化医疗的日益关注。预测期内的主要趋势包括诊断技术的创新、分子诊断技术的进步、生技药品的进步、个人化医疗的兴起以及策略联盟。

预计胃肠道疾病的日益普及将在不久的将来推动胃肠道粪便检验市场的成长。胃肠道疾病包括影响胃、肠和相关器官等消化器官系统的疾病，会导致噁心、腹泻、便秘和腹痛等症状。此类疾病的增加主要归因于不良的饮食习惯，例如加工食品摄取量增加、高糖摄取和低纤维饮食。这些因素会扰乱肠道菌群，损害消化器官系统健康，并导致胃酸逆流、大肠激躁症躁症(IBS) 和发炎性肠道疾病肠道疾病(IBD) 等症状。胃肠道粪便检验对于诊断这些疾病至关重要，因为它可以透过检测病原体（细菌、病毒和寄生虫）、肠道发炎标记和消化酵素缺乏症来帮助识别感染疾病、发炎和消化器官系统失衡。这有助于准确诊断和有针对性的治疗。例如，美国疾病管制与预防中心 (CDC) 于 2024 年 9 月报告称，2024 年至 2025 年期间，参与诺罗病毒统计的各州共发生 1676 起诺罗病毒疫情，较去年同期记录的 729 例大幅增加。因此，胃肠道疾病盛行率的上升正在推动胃肠道粪便检验市场的成长。

医疗保健基础设施的扩张预计将进一步推动胃肠道粪便检验市场的成长。医疗保健基础设施包括提供医疗保健服务所需的实体、技术和组织系统，例如医院、诊所、设备和数位医疗系统。人口成长和老化推动了基础设施的扩张，因为更长的预期寿命和更高的疾病盛行率需要更多的医疗保健设施来确保充足的医疗服务可及性并改善患者预后。加强医疗保健基础设施可以透过提供先进的实验室设施、诊断技术和训练有素的医疗专业人员来提高胃肠道粪便检验的可及性和有效性。因此，胃肠道疾病能够被更快、更准确地检测出来，从而及时治疗并改善患者预后。例如，2024年11月，英国独立慈善机构健康基金会（The Health Foundation）报告称，英国卫生和社会保障部（DHS）的支出预计将从2023/24年度的2276亿美元增至2024/25年度的2386亿美元，再增至2025/26年度的2506亿美元，因此，医疗基础设施的扩张正在支持胃肠道粪便检验市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球GI粪便检验PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球胃肠道粪便检验市场：成长率分析
  • 全球胃肠道粪便检验市场表现：规模与成长，2019-2024 年
  • 全球胃肠道粪便检验市场预测：规模与成长，2024-2029 年，2034 年
  • 全球胃肠道粪便检验总目标市场（TAM）

第六章市场区隔

  • 全球胃肠道粪便检验市场类型、表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 免疫检测
  • 分子诊断检测
  • 基于层析法的测试
  • 微生物培养
  • 酵素免疫分析法（ELISA）
  • 全球胃肠道粪便检验市场（依样本类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 粪便样本
  • 血清样本
  • 全球胃肠道粪便检验市场：按仪器、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 自动分析仪
  • 桌上型装置
  • 行动装置
  • 全球胃肠道粪便检验市场的应用、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 胃肠道疾病的诊断
  • 大肠直肠癌筛检
  • 监测发炎性肠道疾病肠道疾病（IBD）
  • 检测胃肠道感染疾病
  • 评估你的消化器官系统健康
  • 全球胃肠道粪便检验市场（按最终用户、业绩和预测）2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心和实验室
  • 学术机构
  • 研究中心组织
  • 居家护理
  • 其他最终用户
  • 全球胃肠道粪便检验市场按免疫检测测试类型、性能和预测进行细分，2019-2024 年、2024-2029 年、2034 年
  • 快速免疫检测
  • 横向流动化验
  • 萤光免疫分析法
  • 全球胃肠道粪便检验市场细分（按分子诊断检测类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • 核酸增幅检查（NAAT）
  • 次世代定序（NGS）
  • 全球胃肠道粪便检验市场依层析法检测类型细分，实际状况及预测，2019-2024 年、2024-2029 年、2034 年
  • 气相层析法（GC）
  • 液相层析法（LC）
  • 薄层层析法（TLC）
  • 全球胃肠道粪便检验市场按微生物培养检测类型、性能和预测进行细分，2019-2024 年、2024-2029 年、2034 年
  • 需氧培养
  • 厌氧培养
  • 选择性媒体文化
  • 全球胃肠道粪便检验市场酵素免疫分析法（ELISA）细分市场（按类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 直接 ELISA
  • 间接酵素连结免疫吸附试验
  • 夹心 ELISA
  • 竞争性 ELISA

第七章 区域和国家分析

  • 全球胃肠道粪便检验市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球胃肠道粪便检验市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 胃肠道粪便检验市场：竞争格局
  • 胃肠道粪便检验市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Biomerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Meridian BioScience Inc.
  • Diasorin SPA
  • Helena Laboratories Corporation
  • ELITechGroup
  • Genova Diagnostics Inc.
  • Genesis Laboratory Management LLC
  • US BioTek Laboratories LLC
  • Doctor's Data Inc.
  • Diagnostic Solutions Laboratory LLC
  • Serosep Ltd.
  • Atlas Laboratories Ltd.
  • VDI Laboratory LLC
  • Functional Medical Institute Pvt. Ltd.
  • Walk-In Lab LLC
  • ScheBo Biotech AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年胃肠粪便检验市场：提供新机会的国家
  • 2029 年胃肠粪便检验市场：细分市场带来新机会
  • 2029 年胃肠道粪便检验市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r34862

Gastrointestinal (GI) stool testing involves analyzing stool samples to evaluate gastrointestinal health, detect infections, digestive disorders, and inflammatory conditions. It aids in identifying microbial imbalances, digestive enzyme deficiencies, and markers of gut inflammation, making it a non-invasive diagnostic tool for early disease detection and personalized treatment planning.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of GI stool tests include immunoassay tests, molecular diagnostic tests, chromatography-based tests, microbiological culture tests, and enzyme-linked immunosorbent assay (ELISA). An immunoassay test is a diagnostic method that uses antibodies to identify specific antigens or proteins in stool samples. It can use both fecal and serum samples and requires various types of equipment, including automated analyzers, benchtop instruments, and portable devices. Immunoassay tests are used for diagnosing gastrointestinal disorders, screening for colorectal cancer, monitoring inflammatory bowel disease (IBD), detecting gastrointestinal infections, and evaluating digestive health. These tests are employed by hospitals, diagnostic centers and laboratories, academic institutions, research organizations, home care settings, and others.

The GI stool testing market research report is one of a series of new reports from The Business Research Company that provides GI stool testing market statistics, including GI stool testing industry global market size, regional shares, competitors with a GI stool testing market share, detailed GI stool testing market segments, market trends and opportunities, and any further data you may need to thrive in the GI stool testing industry. This GI stool testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The GI stool testing market size has grown strongly in recent years. It will grow from$1.32 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising prevalence of gastrointestinal diseases, increasing awareness of gut health, greater adoption of automated systems, growing disposable income, and the expanding geriatric population.

The GI stool testing market size is expected to see strong growth in the next few years. It will grow to$1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing demand for efficient diagnostic instruments, the rising prevalence of colorectal cancer, higher healthcare expenditure, growing consumption of fast food, and an increasing focus on personalized medicine. Major trends in the forecast period include innovations in diagnostic technologies, advancements in molecular diagnostics, progress in biologics, the rise of personalized medicine, and strategic collaborations.

The growing prevalence of gastrointestinal disorders is anticipated to drive the growth of the GI stool testing market in the near future. Gastrointestinal disorders encompass conditions that affect the digestive system, including the stomach, intestines, and related organs, leading to symptoms such as nausea, diarrhea, constipation, and abdominal pain. The rise in such disorders is mainly attributed to poor dietary habits, including increased consumption of processed foods, high sugar intake, and low-fiber diets. These factors disrupt gut microbiota, impair digestive health, and contribute to conditions such as acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is essential for diagnosing these conditions as it helps identify infections, inflammation, or digestive imbalances by detecting pathogens (bacteria, viruses, parasites), markers of gut inflammation, and digestive enzyme deficiencies. This enables accurate diagnosis and targeted treatment. For example, in September 2024, the Centers for Disease Control and Prevention (CDC) reported 1,676 norovirus outbreaks in NoroSTAT-participating states between 2024 and 2025, marking a significant increase from the 729 outbreaks recorded during the same period the previous year. Thus, the rising prevalence of gastrointestinal disorders is fueling the growth of the GI stool testing market.

The expansion of healthcare infrastructure is expected to further propel the growth of the GI stool testing market. Healthcare infrastructure includes the physical, technological, and organizational systems needed to deliver medical services, such as hospitals, clinics, equipment, and digital health systems. The expansion of this infrastructure is driven by increasing populations and aging demographics, as longer life expectancies and a higher prevalence of diseases necessitate more medical facilities to ensure adequate healthcare access and improved patient outcomes. Enhanced healthcare infrastructures improve the accessibility and effectiveness of GI stool testing by providing advanced laboratory facilities, diagnostic technologies, and better-trained medical professionals. This leads to faster and more accurate detection of gastrointestinal disorders, enabling timely treatment and better patient outcomes. For instance, in November 2024, The Health Foundation, a UK-based independent charity, reported that the Department of Health and Social Care's spending is expected to increase from $227.6 billion in 2023/24 to $238.6 billion in 2024/25, and $250.6 billion in 2025/26, reflecting an average annual real-term growth of 3.3%. As such, the expansion of healthcare infrastructure supports the growth of the GI stool testing market.

Leading companies in the GI stool testing market are prioritizing advanced diagnostic technologies, such as comprehensive tests, to improve accuracy, speed, and early detection of diseases. Comprehensive diagnostic tests evaluate multiple health parameters at once, offering a thorough assessment of a condition. For example, in November 2024, EmeritusDX, a US-based diagnostics company, launched GI Detect, a comprehensive diagnostic test designed to assist healthcare providers in diagnosing gastrointestinal disorders. This innovative test uses a single stool swab to detect 26 bacteria, viruses, and parasites associated with digestive system disturbances. With a 24-hour turnaround time, GI Detect allows for fast and informed clinical decision-making. In addition to broad pathogen detection, the test screens for Helicobacter pylori and its virulence factors-VacA, cagA, and babA-along with common gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This comprehensive approach ensures accurate and timely diagnosis of gastrointestinal infections.

Major players in the GI stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, Helena Laboratories Corporation, ELITechGroup, Genova Diagnostics Inc., Genesis Laboratory Management LLC, US BioTek Laboratories LLC, Doctor's Data Inc., Diagnostic Solutions Laboratory LLC, Serosep Ltd., Atlas Laboratories Ltd., VDI Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, and ScheBo Biotech AG.

North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in GI stool testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the GI stool testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The GI stool testing market consists of revenues earned by entities by providing services such as microbiome analysis, pathogen detection, colorectal cancer screening, digestive health assessment, and inflammatory marker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The GI stool testing market also includes sales of stool test kits, reagent solutions, sample collection devices, diagnostic analyzers, and laboratory consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

GI Stool Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gi stool testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gi stool testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gi stool testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Immunoassay Test; Molecular Diagnostic Test; Chromatography-Based Test; Microbiological Culture Test; Enzyme-Linked Immunosorbent Assay (ELISA)
  • 2) By Sample Type: Fecal Samples; Serum Samples
  • 3) By Equipment: Automated Analyzers; Benchtop Instruments; Portable Devices
  • 4) By Application: Diagnosis Of Gastrointestinal Disorders; Screening For Colorectal Cancer; Monitoring Of Inflammatory Bowel Disease (IBD); Detection Of Gastrointestinal Infections; Evaluation Of Digestive Health
  • 5) By End User: Hospital; Diagnostic Centre And Laboratory; Academic Institution; Research Centre Organization; Homecare; Other End Users
  • Subsegments:
  • 1) By Immunoassay Test: Rapid Immunoassay; Lateral Flow Assay; Fluorescent Immunoassay
  • 2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Test (NAAT); Next-Generation Sequencing (NGS)
  • 3) By Chromatography-Based Test: Gas Chromatography (GC); Liquid Chromatography (LC); Thin-Layer Chromatography (TLC)
  • 4) By Microbiological Culture Test: Aerobic Culture; Anaerobic Culture; Selective Media Culture
  • 5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA; Competitive ELISA
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Hologic Inc.; Biomerieux SA; Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. GI Stool Testing Market Characteristics

3. GI Stool Testing Market Trends And Strategies

4. GI Stool Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global GI Stool Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global GI Stool Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global GI Stool Testing Market Growth Rate Analysis
  • 5.4. Global GI Stool Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global GI Stool Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global GI Stool Testing Total Addressable Market (TAM)

6. GI Stool Testing Market Segmentation

  • 6.1. Global GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Test
  • Molecular Diagnostic Test
  • Chromatography-Based Test
  • Microbiological Culture Test
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • 6.2. Global GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fecal Samples
  • Serum Samples
  • 6.3. Global GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Analyzers
  • Benchtop Instruments
  • Portable Devices
  • 6.4. Global GI Stool Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnosis Of Gastrointestinal Disorders
  • Screening For Colorectal Cancer
  • Monitoring Of Inflammatory Bowel Disease (IBD)
  • Detection Of Gastrointestinal Infections
  • Evaluation Of Digestive Health
  • 6.5. Global GI Stool Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Diagnostic Centre And Laboratory
  • Academic Institution
  • Research Centre Organization
  • Homecare
  • Other End Users
  • 6.6. Global GI Stool Testing Market, Sub-Segmentation Of Immunoassay Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Immunoassay
  • Lateral Flow Assay
  • Fluorescent Immunoassay
  • 6.7. Global GI Stool Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Nucleic Acid Amplification Test (NAAT)
  • Next-Generation Sequencing (NGS)
  • 6.8. Global GI Stool Testing Market, Sub-Segmentation Of Chromatography-Based Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gas Chromatography (GC)
  • Liquid Chromatography (LC)
  • Thin-Layer Chromatography (TLC)
  • 6.9. Global GI Stool Testing Market, Sub-Segmentation Of Microbiological Culture Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aerobic Culture
  • Anaerobic Culture
  • Selective Media Culture
  • 6.10. Global GI Stool Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA

7. GI Stool Testing Market Regional And Country Analysis

  • 7.1. Global GI Stool Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global GI Stool Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific GI Stool Testing Market

  • 8.1. Asia-Pacific GI Stool Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China GI Stool Testing Market

  • 9.1. China GI Stool Testing Market Overview
  • 9.2. China GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India GI Stool Testing Market

  • 10.1. India GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan GI Stool Testing Market

  • 11.1. Japan GI Stool Testing Market Overview
  • 11.2. Japan GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia GI Stool Testing Market

  • 12.1. Australia GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia GI Stool Testing Market

  • 13.1. Indonesia GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea GI Stool Testing Market

  • 14.1. South Korea GI Stool Testing Market Overview
  • 14.2. South Korea GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe GI Stool Testing Market

  • 15.1. Western Europe GI Stool Testing Market Overview
  • 15.2. Western Europe GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK GI Stool Testing Market

  • 16.1. UK GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany GI Stool Testing Market

  • 17.1. Germany GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France GI Stool Testing Market

  • 18.1. France GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy GI Stool Testing Market

  • 19.1. Italy GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain GI Stool Testing Market

  • 20.1. Spain GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe GI Stool Testing Market

  • 21.1. Eastern Europe GI Stool Testing Market Overview
  • 21.2. Eastern Europe GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia GI Stool Testing Market

  • 22.1. Russia GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America GI Stool Testing Market

  • 23.1. North America GI Stool Testing Market Overview
  • 23.2. North America GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA GI Stool Testing Market

  • 24.1. USA GI Stool Testing Market Overview
  • 24.2. USA GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada GI Stool Testing Market

  • 25.1. Canada GI Stool Testing Market Overview
  • 25.2. Canada GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America GI Stool Testing Market

  • 26.1. South America GI Stool Testing Market Overview
  • 26.2. South America GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil GI Stool Testing Market

  • 27.1. Brazil GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East GI Stool Testing Market

  • 28.1. Middle East GI Stool Testing Market Overview
  • 28.2. Middle East GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa GI Stool Testing Market

  • 29.1. Africa GI Stool Testing Market Overview
  • 29.2. Africa GI Stool Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa GI Stool Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa GI Stool Testing Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. GI Stool Testing Market Competitive Landscape And Company Profiles

  • 30.1. GI Stool Testing Market Competitive Landscape
  • 30.2. GI Stool Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Biomerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. GI Stool Testing Market Other Major And Innovative Companies

  • 31.1. Meridian BioScience Inc.
  • 31.2. Diasorin SPA
  • 31.3. Helena Laboratories Corporation
  • 31.4. ELITechGroup
  • 31.5. Genova Diagnostics Inc.
  • 31.6. Genesis Laboratory Management LLC
  • 31.7. US BioTek Laboratories LLC
  • 31.8. Doctor's Data Inc.
  • 31.9. Diagnostic Solutions Laboratory LLC
  • 31.10. Serosep Ltd.
  • 31.11. Atlas Laboratories Ltd.
  • 31.12. VDI Laboratory LLC
  • 31.13. Functional Medical Institute Pvt. Ltd.
  • 31.14. Walk-In Lab LLC
  • 31.15. ScheBo Biotech AG

32. Global GI Stool Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The GI Stool Testing Market

34. Recent Developments In The GI Stool Testing Market

35. GI Stool Testing Market High Potential Countries, Segments and Strategies

  • 35.1 GI Stool Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 GI Stool Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 GI Stool Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34862_GI_Stool_Testing_GMR_2025